Life Sciences

Only two future events are certain – death, and disruption of the status quo

Introducing “Redefining Innovation: Embracing The 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry” There is a crisis of innovation for incumbents in the biopharmaceutical industry that should concern all of us. Once innovators who were responsible for some of the most significant advances in medical care the human race has seen, these organizations have 

Continue Reading…

Pharma Companies, Escape the Black Hole of the conventional!

The pharmaceutical industry lives and breathes innovation, yet the nature of its products, and their direct relationship to human health necessitates the most conservative and methodical levels of control and oversight, to meet compliance, as driven by stringent regulations. Conventional safety frameworks, manually intensive processes and legacy systems create barriers to efficiency and innovation for 

Continue Reading…